Semaglutide vs liraglutide treatment demonstrated superior weight loss at 1 year and 10% weight loss achievement among patients with obesity.

India’s powerful copycat pharmaceutical industry is set to roll out generic weight loss drugs in the U.K. within weeks ...

The U.K. is exploring whether obesity drugs could be used to curb joblessness after signing a major investment deal with weight-loss treatment giant, Eli Lilly.

Britain will study whether the use of Eli Lilly's weight loss drug can get people back into work and help tackle the high ...

The Food and Drug Administration (FDA) said it will reconsider its decision to remove Eli Lilly’s blockbuster weight loss and diabetes drug from its official shortage list and allow compounding ...

We recently compiled a list of the 10 Most Promising Growth Stocks According to Hedge Funds. In this article, we are going to ...

A recent study published by the Journal of the American Medical Association (JAMA) found that patients taking the drugs ...

Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a ...

The surge in popularity of drugs like Ozempic, driven in part by its weight loss benefits, is contributing to a record-high ...

StudyFinds' Dr. Faith Coleman looks at the common mistakes patients make using GLP-1 agonists like Ozempic and Wegovy.

The co-founder of biotech giant Regeneron Pharmaceuticals (REGN) recently raised concerns about the potential side effects of ...

Only a fifth of large U.S. companies cover pricey GLP-1 weight-loss drugs like Wegovy and Zepbound in their health insurance ...